PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-09-01

Date Title Company
01-Sep-2022 APONTIS PHARMA: SECURE study and START study add-on analysis confirm superior efficacy of Single Pill APONTIS PHARMA AG
01-Sep-2022 Zur Rose Group successfully completes placement of approx. CHF 95 million Convertible Bonds and the approx. CHF 44 million Capital Increase by way of an accelerated book building process Zur Rose Group AG